Ignite Creation Date:
2025-12-24 @ 7:51 PM
Ignite Modification Date:
2026-03-29 @ 11:49 PM
Study NCT ID:
NCT02715804
Status:
TERMINATED
Last Update Posted:
2020-07-14
First Post:
2016-03-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma
Sponsor:
Halozyme Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HALO-109-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None